What you need to know about the Ozempic pill

What’s different about the Ozempic pill? The pharmaceutical company Novo Nordisk announced in a press release this week that the Ozempic pill is “the only oral GLP-1 medicine approved for both primary ...

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
Healthline

New Ozempic Pill Could Revolutionize Type 2 Diabetes Treatment. Here's How

Ozempic is now available in pill form for people with type 2 diabetes. Novo Nordisk says the oral GLP-1's new lower-dose ...

Is the weight-loss drug boom moving past the Ozempic era?

Novo reported 1.3 million prescriptions for its weight-loss pill, which is now available in the U.S., in the first quarter of ...

Healthy returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in ...

Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

Novo Nordisk A/S saw a 40% surge in sales of its diabetes and weight-loss drugs in India last month, after steep price cuts ...

Inside the town Ozempic built

On a boat off Kalundborg harbor, Martin Høgh Sørensen steers while his wife, Karin, and friends Michael and Anne-Louise ...

The Wegovy pill saw the fastest take-up in weight-loss drug history. Novo Nordisk only narrowly lifted guidance.

Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling ...